X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (138) 138
female (124) 124
index medicus (111) 111
oncology (98) 98
middle aged (90) 90
breast cancer (86) 86
aged (67) 67
breast neoplasms - drug therapy (67) 67
adult (63) 63
cancer (63) 63
article (48) 48
chemotherapy (43) 43
breast neoplasms - pathology (35) 35
care and treatment (31) 31
treatment outcome (29) 29
women (27) 27
risk factors (25) 25
breast neoplasms - genetics (23) 23
aged, 80 and over (22) 22
health aspects (22) 22
survivors (21) 21
abridged index medicus (18) 18
antineoplastic agents - adverse effects (18) 18
antineoplastic combined chemotherapy protocols - therapeutic use (18) 18
tumors (18) 18
trastuzumab (17) 17
disease-free survival (16) 16
medicine & public health (16) 16
metastasis (16) 16
neoadjuvant therapy (16) 16
neoplasm staging (16) 16
therapy (16) 16
antineoplastic agents - therapeutic use (15) 15
breast neoplasms - metabolism (15) 15
expression (15) 15
male (15) 15
quality-of-life (15) 15
research (15) 15
survival (15) 15
analysis (14) 14
aromatase inhibitors - adverse effects (14) 14
breast-cancer (14) 14
risk (14) 14
adjuvant treatment (13) 13
diagnosis (13) 13
postmenopausal women (13) 13
prognosis (13) 13
retrospective studies (13) 13
breast neoplasms - complications (12) 12
breast neoplasms - therapy (12) 12
cancer therapies (12) 12
clinical trials (12) 12
patients (12) 12
biomarkers (11) 11
breast neoplasms - mortality (11) 11
breast neoplasms - psychology (11) 11
cancer patients (11) 11
cancer survivors (11) 11
case-control studies (11) 11
chemotherapy, adjuvant (11) 11
cohort studies (11) 11
drug therapy (11) 11
genetic aspects (11) 11
genotype (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
aromatase inhibitors - therapeutic use (10) 10
epidemiology (10) 10
estrogen (10) 10
medical colleges (10) 10
metastases (10) 10
trial (10) 10
womens health (10) 10
young adult (10) 10
adjuvant chemotherapy (9) 9
breast neoplasms - immunology (9) 9
cells (9) 9
cross-sectional studies (9) 9
logistic models (9) 9
medicine (9) 9
neoadjuvant chemotherapy (9) 9
neoplasm metastasis (9) 9
postmenopause (9) 9
prospective studies (9) 9
randomized-trial (9) 9
symptoms (9) 9
time factors (9) 9
animals (8) 8
arthralgia - chemically induced (8) 8
breast neoplasms - blood (8) 8
combination (8) 8
dose-response relationship, drug (8) 8
epidermal growth factor (8) 8
erbb-2 protein (8) 8
genomics (8) 8
management (8) 8
polymorphism, single nucleotide (8) 8
public, environmental & occupational health (8) 8
research article (8) 8
surveys and questionnaires (8) 8
survival analysis (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 425 - 439
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 4, pp. 395 - 405
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2017, Volume 70, Issue 2, pp. 152 - 162
Oxidative/nitrosative stress and endothelial dysfunction are hypothesized to be central to cancer therapeutics–related cardiac dysfunction (CTRCD). However,... 
trastuzumab | cardiotoxicity | nitrosative stress | arginine metabolism | cardio-oncology | doxorubicin | CARDIAC & CARDIOVASCULAR SYSTEMS | ENDOTHELIAL DYSFUNCTION | DOXORUBICIN TREATMENT | HEART-FAILURE | CARDIOMYOPATHY | ASYMMETRIC DIMETHYLARGININE ADMA | SYNTHASE | INDUCED CARDIOTOXICITY | ANTHRACYCLINE | CARDIOVASCULAR-DISEASE | Doxorubicin - therapeutic use | Nitric Oxide - blood | Cardiomyopathies - blood | Prospective Studies | Trastuzumab - therapeutic use | Follow-Up Studies | Oxidative Stress | Humans | Middle Aged | Antibiotics, Antineoplastic - adverse effects | Trastuzumab - adverse effects | Antineoplastic Agents - therapeutic use | Breast Neoplasms - drug therapy | Biomarkers, Tumor - blood | Breast Neoplasms - complications | Antibiotics, Antineoplastic - therapeutic use | Time Factors | Antineoplastic Agents - adverse effects | Arginine - blood | Breast Neoplasms - blood | Adult | Female | Doxorubicin - adverse effects | Cardiomyopathies - chemically induced | Medical colleges | Care and treatment | Breast cancer | Epidemiology | Homeopathy | Materia medica and therapeutics | Endothelium | Cancer patients | Metabolites | Arginine | Cardiac patients | Nitric oxide | Therapeutics | Cardiology | Anthracyclines | Endothelial growth factors | Analysis | Oxidative stress | Cardiomyopathy | Oncology | Cardiovascular disease | Cancer therapies | Doxorubicin | Body mass index | Ultrasonic imaging | Measurement techniques | Bioindicators | Heart diseases | Age | Heart failure | Hypertension | Echocardiography | Mortality | Cardiomyocytes | Bioavailability | Citrulline | Patients | Chromatography | Studies | Chemotherapy | Body mass | Coronary vessels | Biomarkers | Breast | Scientific imaging | Plasma levels | Ornithine | Mass spectrometry | Trastuzumab | Polymethyl methacrylate | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 4/2012, Volume 132, Issue 3, pp. 1049 - 1062
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 02/2017, Volume 195, Issue 3, pp. 360 - 368
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 20, pp. 1926 - 1936
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2016, Volume 375, Issue 1, pp. 23 - 34
Journal Article